Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02782247
What this trial is testing

Dynamic Liver Tests in Liver Disease

Who this might be right for
Hepatitis BHepatitis C
Queen Mary University of London 52
Early research (Phase 1)Study completedNCT00971308
What this trial is testing

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 37
Not applicableStudy completedNCT00209118
What this trial is testing

Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C

Who this might be right for
Hepatitis CDepressionInterferon-alpha Associated Side Effects
Emory University 60
Early research (Phase 1)Study completedNCT01181024
What this trial is testing

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 82
Large-scale testing (Phase 3)Study completedNCT01935817
What this trial is testing

Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV

Who this might be right for
Liver Fibrosis
University of Catania 64
Testing effectiveness (Phase 2)Study completedNCT03379506
What this trial is testing

Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)

Who this might be right for
HCV Infection
Merck Sharp & Dohme LLC 57
Large-scale testing (Phase 3)Study completedNCT01604850
What this trial is testing

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 202
Very early researchUnknownNCT03882307
What this trial is testing

Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera

Who this might be right for
Hepatitis C, Chronic
Assiut University 40
Testing effectiveness (Phase 2)Ended earlyNCT00800007
What this trial is testing

Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Anza Therapeutics, Inc. 5
Not applicableStudy completedNCT02582671
What this trial is testing

The Effectiveness of ABT-450/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C -An Observational Study in Ireland

Who this might be right for
Chronic Hepatitis C
AbbVie 101
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Testing effectiveness (Phase 2)Study completedNCT00118768
What this trial is testing

Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 175
Not applicableStudy completedNCT02402218
What this trial is testing

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
Johns Hopkins University 144
Early research (Phase 1)Ended earlyNCT01425190
What this trial is testing

Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)UnknownNCT00526448
What this trial is testing

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Who this might be right for
Chronic Hepatitis C
Hospital Carlos III, Madrid 384
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Post-approval studies (Phase 4)Ended earlyNCT03723824
What this trial is testing

Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation

Who this might be right for
Chronic Hepatitis cLiver Transplant InfectionKidney Transplant Infection
Taichung Veterans General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT01200420
What this trial is testing

Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C Subjects

Who this might be right for
Hepatitis C
Santaris Pharma A/S 38
Not applicableStudy completedNCT00629603
What this trial is testing

Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease

Who this might be right for
FibrosisChronic Liver Disease
Kaohsiung Medical University Chung-Ho Memorial Hospital 600
Not applicableActive Not RecruitingNCT03993925
What this trial is testing

Enhancing Access to Care for Chronic Hepatitis C Infected Populations in Hong Kong

Who this might be right for
Chronic Hepatitis CIntravenous Drug Usage
The University of Hong Kong 800
Next Page